Genomic profiling in Bulgarian women with ovarian cancer: a dual-sample NGS approach.

Hered Cancer Clin Pract · 2026 · PMC13137463 · PMID 41882704

Europe PMC DOI

hedged sentence

0.3770

closest p · 7.5× alpha

0.3770

boldest claim

The sentences

did not reach statistical significancep = 0.377not close (p > 0.1)

Fisher’s exact testing comparing serous versus non-serous tumors indicated a higher likelihood of TP53 alterations in serous carcinomas (OR = 3.0), although this did not reach statistical significance ( p = 0.377), likely reflecting the limited number of non-serous cases.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.